{"sourcedb":"DevicePMAs@therightstef","sourceid":"P950027_S009","text":"Approval for the modification of the manufacturing process for hyalgan for producing hyaluronate by a bacterial fermentation and is indicated for the treatment of pain in osteoarthritis (oa) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy, and to simple analgesics, e. g., acetaminophen.","project":"consensus_PMA_Age_Indications"}